These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Dopaminergic modulation of striatal function and Parkinson's disease. Zhai S; Shen W; Graves SM; Surmeier DJ J Neural Transm (Vienna); 2019 Apr; 126(4):411-422. PubMed ID: 30937538 [TBL] [Abstract][Full Text] [Related]
4. Levodopa-induced changes in synaptic dopamine in patients with Parkinson's disease as measured by [11C]raclopride displacement and PET. Tedroff J; Pedersen M; Aquilonius SM; Hartvig P; Jacobsson G; Långström B Neurology; 1996 May; 46(5):1430-6. PubMed ID: 8628494 [TBL] [Abstract][Full Text] [Related]
5. Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease. Francardo V; Recchia A; Popovic N; Andersson D; Nissbrandt H; Cenci MA Neurobiol Dis; 2011 Jun; 42(3):327-40. PubMed ID: 21310234 [TBL] [Abstract][Full Text] [Related]
6. A Subpopulation of Striatal Neurons Mediates Levodopa-Induced Dyskinesia. Girasole AE; Lum MY; Nathaniel D; Bair-Marshall CJ; Guenthner CJ; Luo L; Kreitzer AC; Nelson AB Neuron; 2018 Feb; 97(4):787-795.e6. PubMed ID: 29398356 [TBL] [Abstract][Full Text] [Related]
7. Eltoprazine prevents levodopa-induced dyskinesias by reducing striatal glutamate and direct pathway activity. Paolone G; Brugnoli A; Arcuri L; Mercatelli D; Morari M Mov Disord; 2015 Nov; 30(13):1728-38. PubMed ID: 26207892 [TBL] [Abstract][Full Text] [Related]
8. Pathophysiology of the basal ganglia in Parkinson's disease. Obeso JA; Rodríguez-Oroz MC; Rodríguez M; Lanciego JL; Artieda J; Gonzalo N; Olanow CW Trends Neurosci; 2000 Oct; 23(10 Suppl):S8-19. PubMed ID: 11052215 [TBL] [Abstract][Full Text] [Related]
9. Levodopa-induced dyskinesias in Parkinson's disease: etiology, impact on quality of life, and treatments. Encarnacion EV; Hauser RA Eur Neurol; 2008; 60(2):57-66. PubMed ID: 18480609 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of levodopa dose and magnitude of dopamine depletion as risk factors for levodopa-induced dyskinesia in a rat model of Parkinson's disease. Putterman DB; Munhall AC; Kozell LB; Belknap JK; Johnson SW J Pharmacol Exp Ther; 2007 Oct; 323(1):277-84. PubMed ID: 17660384 [TBL] [Abstract][Full Text] [Related]
11. Neurobiology of l-DOPA induced dyskinesia and the novel therapeutic strategies. Sharma S; Singh S; Sharma V; Singh VP; Deshmukh R Biomed Pharmacother; 2015 Mar; 70():283-93. PubMed ID: 25776513 [TBL] [Abstract][Full Text] [Related]
12. Serotonergic markers in Parkinson's disease and levodopa-induced dyskinesias. Cheshire P; Ayton S; Bertram KL; Ling H; Li A; McLean C; Halliday GM; O'Sullivan SS; Revesz T; Finkelstein DI; Storey E; Williams DR Mov Disord; 2015 May; 30(6):796-804. PubMed ID: 25649148 [TBL] [Abstract][Full Text] [Related]
13. Implanted reuptake-deficient or wild-type dopaminergic neurons improve ON L-dopa dyskinesias without OFF-dyskinesias in a rat model of Parkinson's disease. Vinuela A; Hallett PJ; Reske-Nielsen C; Patterson M; Sotnikova TD; Caron MG; Gainetdinov RR; Isacson O Brain; 2008 Dec; 131(Pt 12):3361-79. PubMed ID: 18988638 [TBL] [Abstract][Full Text] [Related]
17. Striatal glutamate induces retrograde excitotoxicity and neuronal degeneration of intralaminar thalamic nuclei: their potential relevance for Parkinson's disease. Morales I; Sabate M; Rodriguez M Eur J Neurosci; 2013 Jul; 38(1):2172-82. PubMed ID: 23565852 [TBL] [Abstract][Full Text] [Related]
18. Altered D(1) dopamine receptor trafficking in parkinsonian and dyskinetic non-human primates. Guigoni C; Doudnikoff E; Li Q; Bloch B; Bezard E Neurobiol Dis; 2007 May; 26(2):452-63. PubMed ID: 17350277 [TBL] [Abstract][Full Text] [Related]
19. Genetic lack of histamine upregulates dopamine neurotransmission and alters rotational behavior but not levodopa-induced dyskinesia in a mouse model of Parkinson's disease. Koski SK; Leino S; Panula P; Rannanpää S; Salminen O Neurosci Lett; 2020 Jun; 729():134932. PubMed ID: 32224226 [TBL] [Abstract][Full Text] [Related]
20. l-DOPA-induced dyskinesia is associated with a deficient numerical downregulation of striatal tyrosine hydroxylase mRNA-expressing neurons. Klietz M; Keber U; Carlsson T; Chiu WH; Höglinger GU; Weihe E; Schäfer MK; Depboylu C Neuroscience; 2016 Sep; 331():120-33. PubMed ID: 27320210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]